What is Pacific Biosciences?
Pacific Biosciences is a long-read dna sequencing systems company serving enterprise, public-sector, commercial, consumer, or regulated-market customers.
- Category
- Long-read DNA sequencing systems
- Headquarters
- Menlo Park, CA
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: PACB
What is Pacific Biosciences?
Pacific Biosciences is a long-read dna sequencing systems company headquartered in Menlo Park, CA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Pacific Biosciences is a long-read dna sequencing systems company headquartered in Menlo Park, CA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Pacific Biosciences should be mapped as a scaled public-company account rather than an early-stage company. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Pacific Biosciences offer?
Pacific Biosciences's profile centers on HiFi sequencing, Revio system, Onso system, Sequencing consumables.
- HiFi sequencing· Long-read DNA sequencing systems
- Revio system· Long-read DNA sequencing systems
- Onso system· Long-read DNA sequencing systems
- Sequencing consumables· Long-read DNA sequencing systems
- Genomics software· Long-read DNA sequencing systems
- Sample prep· Long-read DNA sequencing systems
How does Pacific Biosciences make money?
Pacific Biosciences makes money through commercial activity tied to long-read dna sequencing systems.
Pacific Biosciences monetizes through the model common to long-read dna sequencing systems: product sales, recurring services, subscriptions, contracts, distribution, transaction volume, underwriting, regulated utility revenue, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, uptime, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Pacific Biosciences?
Pacific Biosciences's named executives should be verified on the official leadership or investor-relations page before outreach.
- Pacific Biosciences executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Pacific Biosciences finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Pacific Biosciences operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Pacific Biosciences's leadership?
Pacific Biosciences should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.pacb.com- Pacific Biosciences investor relationsInvestor relations / corporate contactcontact via https://www.pacb.com
- Pacific Biosciences media relationsMedia or communications contact routecontact via https://www.pacb.com
How is Pacific Biosciences funded?
Pacific Biosciences's current status is Public company; Nasdaq: PACB.
Pacific Biosciences's capital profile is best understood through its current public-company status: Public company; Nasdaq: PACB. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capex plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Pacific Biosciences get here?
Pacific Biosciences's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingPacific Biosciences is foundedThe company begins building in long-read dna sequencing systems.
- Scale-upCommercial footprint expandsPacific Biosciences broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: PACBPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Pacific Biosciences's competitors?
Pacific Biosciences competes with larger incumbents and focused specialists in long-read dna sequencing systems.
- Thermo Fisher ScientificLife sciences tools, diagnostics, and services incumbent.
- DanaherLife sciences and diagnostics platform company.
- MedtronicGlobal medical technology competitor.
- PfizerLarge pharmaceutical company with global commercial reach.
- IQVIAHealthcare data and clinical research platform competitor.
Pacific Biosciences — frequently asked questions
